Efficacy of cardiac biofeedback in control shortness of breath and improving functional capacity in COVID-19 survivors

Not Applicable

• Conditions: Acute Post-COVID-19 syndrome; C01.748.610.763.500

• Registration Number: RBR-2rvwstz
• Lead Sponsor: nifacisa

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2024-02-08
• Last Update Posted: 5 March 2024
• Study Completion: 2024-04-24

Recruitment & Eligibility

• Status: Other
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Patients who prove RT-PCR negative for COVID-19 performed at the place of hospitalization following criteria for hospital discharge; who developed a moderate to severe form of the disease; who were hospitalized and admitted to an intensive care unit (ICU) will be included in the study, intermediate care unit or ward; undergoing invasive (via orotracheal tube or tracheostomy) or non-invasive mechanical ventilation and oxygen therapy (high-flow nasal atheter or mask with reservoir bag); who were discharged at least 30 days before the start of rehabilitation.

Exclusion Criteria

Participants who certify reinfection, rehospitalization and hospital admission will be excluded from the study; hemodynamically unstable patients (uncontrolled blood pressure and heart rate); unstable medical conditions (e.g., cardiovascular and pulmonary disorders - arrhythmias, decompensated atrial fibrillation, pulmonary thromboembolism, acute heart failure, pulmonary congestion, acute myocardial infarction and stroke); with severe pulmonary, cardiac or functional sequelae that require a more complete rehabilitation program, or cognitive conditions; dementia that makes it impossible to answer the questionnaires; finally those with confirmed mental disorders and who require sychological intervention.

Study & Design

• Study Type: Intervention
• Study Design: Not specified